Escherichia coli sequence type 131 is a dominant, antimicrobial- resistant clonal group associated with healthcare and elderly hosts

Infection Control and Hospital Epidemiology

Volumn 34, Issue 4, 2013, Pages 361-369

  Banerjee, Ritu ^a   Johnston, Brian ^b   Lohse, Christine ^a   Porter, Stephen B ^b   Clabots, Connie ^b   Johnson, James R ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; COHORT ANALYSIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENE SEQUENCE; HEALTH CARE PERSONNEL; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MINNESOTA; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84874920229     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/669865     Document Type: Article

References (34)

1. Coque T, Baquero F, Canton R. Increasing prevalence of ESBL- producing enterobacteriaceae in Europe. Eurosurveillance 2008; 13:1-11.
2. Nicolas-Chanoine M-H, Blanco J, Leflon-Guibout V, et al. In- tercontinental emergence of Escherichia coli clone O25:H4- ST131 producing CTX-M-15. J Antimicrob Chemother 2008;61: 273-281.
3. Peirano G, Pitout J. Molecular epidemiology of Escherichia coli producing CTX-M-beta lactamases: the wordwide emergence of clone ST131 O25:H4 Int J Antimicrob Agents 2009;35:316-321.
4. Johnson J, Johnston B, Clabots C, Kuskowski M, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010;51:286-294.
5. Yokota S, Sato T, Okubo T, et al. Prevalence of fluoroquinolone- resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonpro- ducing) strains isolated in Japan. Chemother 2012;58:52-59.
6. Rogers B, Sidjabat H, Paterson D. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J An- timicrob Chemother 2011;66:1-14.
7. Cagnacci S, Gualco L, Debbia E, Schito G, Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST131 and O15:K52:H1 causing community- acquired uncomplicated cystitis. J Clin Microbiol 2008;46:2605-2612.
8. Livermore D, Canton R, Gniadkowski M, et al. CTX-M: chang- ing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59:165-174.
9. Johnson J, Urban C, Weissman S, et al. Molecular epidemio- logical analysis of Escherichia coli sequence type ST131 (O25: H4) and blaCTX-M-15 among extended spectrum beta-lactamase producing E. coli from the United States, 2000-2009. Antimicrob Agents Chemother 2012;56:2364-2370.
10. Johnson J, Nicolas-Chanoine M-H, DebRoy C, et al. Compar- ison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 2012;18:598-607.
11. Owens R, Johnson J, Stogsdill P, Yarmus L, Lolans K, Quinn J. Community transmission in the United States of a CTX-M-15- producing sequence type ST131 Escherichia coli strain resulting in death. J Clin Microbiol 2011;49:3406-3408.
12. Vincent C, Boerlin P, Daignault D, et al. Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis 2010;16:88-95.
13. Swami S, Liesinger J, Shah N, Baddour L, Banerjee R. Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olm- sted County, Minnesota. Mayo Clin Proc 2012;87:753-759.
14. Clinical and Laboratory Standards Institute. Performance Stan- dards for Antimicrobial Susceptibility Testing: Nineteenth Infor- mational Supplement. CLSI document (M100-S19). Wayne, PA: Clinical and Laboratory Standards Institute, 2009.
15. Clinical and Laboratory Standards Institute. Performance Stan- dards for Antimicrobial Susceptibility Testing: Twentieth Infor- mational Supplement. CLSI document M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute, 2010.
16. Clermont O, Bonacorsi S, Bingen E. Rapid and simple deter- mination of Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-4558.
17. Johnson J, Menard M, Johnston B, Kuskowski M, Nichol K, Zhanel G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002-2004. Antimicrob Agents Chemother 2009;53:2733-2739.
18. Weissman S, Johnson J, Tchesnokova V, et al. High resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol 2012;78:1353-1360.
19. Chung H-C, Lai C-H, Lin J-N, et al. Bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of de- mographic data, clinical features, and mortality. Antimicrob Agents Chemother 2012;56:618-622.
20. Tiruvury H, Johnson J, Mariano N, et al. Identification of CTX- M-beta-lactamases among Escherichia coli from the community in New York City. Diag Microbiol Infect Dis 2012;72:248-252.
21. Blanco M, Alonso MP, Nicolas-Chanoine M-H, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum beta lactamases in Lugo (Spain): dissemination of clone O25b: H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2009; 63:1135-1141.
22. Brisse S, Diancourt L, Laouenan C, et al. Phylogenetic distri- bution of CTX-M and non-ESBL producing Escherichia coli iso- lates: group B2 isolates, except ST131 rarely produce CTX-M enzymes. J Clin Microbiol 2012;50:2974-2981.
23. Burke L, Humphreys H, Fitzgerald-Hughes D. The revolving door between hospital and community: extended-spectrum b- lactamase-producing Escherichia coli in Dublin. J Hosp Infect 2012;81:192-198.
24. Urban C, Mariano N, Bradford PA, et al. Identification of CTX- M-b-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diag Microbiol Infect Dis 2010;66:402-406.
25. Rooney P, O'Leary M, Loughrey A, et al. Nursing homes as a reservoir of extended-spectrum b-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 2009;64:635-641.
26. March A, Aschbacher R, Dhanji H, et al. Colonization of resi- dents and staff of a long term care facility and adjacent acute- care hospital geriatric unit by multiresistant bacteria. Clin Mi- crobiol Infect 2009;16:934-944.
27. Lautenbach E, Han J, Santana E, Tolomeo P, Bilker W, Maslow J. Colonization with extended-spectrum beta-lactamase-pro- ducing Escherichia coli and Klebsiella species in long-term care facility residents. Infect Cont Hosp Epidemiol 2012;33:302-304.
28. Yoo J, Byeon J, Yang J, Yoo J, Chung G, Lee Y. High prevalence of extended-spectrum b-lactamases and plasmid-mediate AmpC b-lactamases in Enterobacteriaceae isolated from long term care facilities in Korea. Diag Microbiol Infect Dis 2010;67:261-265.
29. Gaviria D, Greenfield V, Bixler D, et al. Carbapenem-resistant Klebsiella pneumoniae associated with a long term-care facility, West Virginia, 2009-2011. MMWR Morb Mortal Wkly Rep 2011; 60:1418-1420.
30. Won S, Munoz-Price LS, lolans K, Hota B, Weinstein R, Hayden M. Emergence and rapid regional spread of Klebsiella pneumo- niae carbapenemase producing Enterobacteriaceae. Clin Infect Dis 2011;53:532-540.
31. Wiener J, Quinn J, Bradford P, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281:517-523.
32. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota com- position correlates with diet and health in the elderly. Nature 2012;488:178-185.
33. Johnson J, Porter S, Zhanel G, Kuskowski M, Denamur E. Vir- ulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquino- lone resistance, and virulence genotype. Infect Immun 2012;80: 1554-1562.
34. Lavigne J-P, Bergunst AC, Goret L, et al. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLOS ONE 2012;7:e34294.